HomeInsights52 Week High Stocks

Piramal Pharma Ltd 52 Week High

Piramal Pharma Ltd 52 Week High

stocks purchased

₹ 5.3 Cr

Volume Transacted

(Dec 26, 2024)

stocks purchased

205.6 K

Stocks Traded

(Dec 26, 2024)

Last Updated on: Dec 26, 2024

Image

Piramal Pharma Ltd

NSE: PPLPHARMA

YEARHIGH

₹ 307.85

Last updated on: Dec 26, 2024

Key Highlights

  • The 52 Week HIGH of Piramal Pharma Ltd is ₹ 307.85 as of 26 Dec 24 .

Company Fundamentals for Piramal Pharma Ltd

No data available

Market Price of Piramal Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Piramal Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
26 Dec 2024257.3
24 Dec 2024255.3
23 Dec 2024255.5
20 Dec 2024252.6
19 Dec 2024261.6
18 Dec 2024264.75
17 Dec 2024260.55
16 Dec 2024251.15
13 Dec 2024249.25
12 Dec 2024252

Asset Value vs Market Value of Piramal Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Piramal Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Piramal Pharma Ltd

No data available

* All values are in crore

Piramal Pharma Ltd News Hub

News

Piramal Pharma hits life high on reporting multi-fold jump in Q2 PAT

Revenue from operations grew by 17.28% year on year (YoY) to Rs 2,241.75 crore during the ...

Read more

24 Oct 2024 12:32

News

Piramal Pharma to declare Quarterly Result

Piramal Pharma will hold a meeting of the Board of Directors of the Company on 23 October ...

Read more

15 Oct 2024 10:20

News

Piramal Pharma to invest $80M to expand its Lexington, Kentucky facility

Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Or...

Read more

30 Sep 2024 18:48

News

Piramal Pharma receives SBTi validation for its GHG commitment

Piramal Pharma has embarked on its sustainability journey as the Science Based Targets ini...

Read more

17 Sep 2024 10:14

News

Piramal Pharma grants 48.30 lakh stock options

Piramal Pharma has granted 48,30,836 stock options under Employee Stock Option and Incenti...

Read more

26 Jul 2024 10:05

News

Piramal Pharma Q1 net loss narrows to Rs 89 crore

Revenue from operations grew by 11.57% year on year (YoY) to Rs 1,951.14 crore during the ...

Read more

26 Jul 2024 14:28

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Piramal Pharma Ltd

What is the significance of Piramal Pharma Ltd reaching its 52-week high?

Piramal Pharma Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Piramal Pharma Ltd 52-week high?

Investors monitor Piramal Pharma Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Piramal Pharma Ltd a good buy when it hits its 52-week high?

Whether Piramal Pharma Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Piramal Pharma Ltd fundamentals.

What should I consider before investing in Piramal Pharma Ltd at its 52-week high?

Before investing in Piramal Pharma Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Piramal Pharma Ltd stock price continue to rise after reaching its 52-week high?

Piramal Pharma Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions